Our Tests
About Us
Our Team
Scientific Advisory
Research
Contact Us
News
Oncologica® video follows COVID-19 PCR swab through genomic lab test
Oncologica new research on detection of brain cancer biomarkers by genomic sequencing to improve survival rates
COVID vaccination, PCR testing and variant sequencing: The key to safe cross-border travel
UK Test and Sequence Strategy Aims to Block Emerging COVID-19 Strains
Oncologica®’s Coronafocus COVID-19 Test and Sequence platform enables rapid identification of variants of concern
Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma
Oncologica® launches an integrated Test and Sequence platform to combine high capacity PCR testing with SARS-CoV-2 variant identification
Immunotherapy: an anti-cancer treatment based on harnessing our own immune system to attack cancer cells
Immunotherapy offers hope for men with prostate cancer
Cancer immunotherapy drug “less toxic and prolongs life”
Taking the Oncofocus® Test: Karan’s Testimony
‘Revolutionary’ new class of cancer drugs approved
The most precise treatments with genetic tests
Sherrie Hewson’s brother diagnosed with an “incurable” brain tumour now enlisted the help of a special medical company called Oncologica®
What does personalised medicine mean for you?
Mutations Matter: Cholangiocarcinoma Tumor Profiling Awareness
Genomic Profiling in Sarcoma Shows Potential in Guiding Clinical Management
Immunotherapy: new hope in the battle against cancer
Oncofocus® Cancer Test is now covered by all leading health insurers
Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs
Oncofocus® Cancer Test and targeted therapies. The Revolution in cancer treatment has begun.
Mutation-Targeted Therapy Slows Lung Cancer (NSCLC)
Lung Cancer Driver Discovery May Lead to Novel Therapy for Some Mesothelioma Patients